Novel Approaches to Ovarian Cancer Screening.

Nebgen, Denise R; Lu, Karen H; Bast, Robert C

Nebgen, Denise R; Lu, Karen H; Bast, Robert C.

Afiliação

Nebgen DR; Division of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Lu KH; Division of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Bast RC; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. rbast@mdanderson.org.

Curr Oncol Rep ; 21(8): 75, 2019 07 26.

Article em En | MEDLINE | ID: mdl-31346778

Assuntos

Detecção Precoce de Câncer; Neoplasias Ovarianas/diagnóstico; Biomarcadores Tumorais/sangue; Tubas Uterinas/patologia; Feminino; Humanos; Neoplasias Ovarianas/sangue; Neoplasias Ovarianas/diagnóstico por imagem; Neoplasias Ovarianas/patologia; Teste de Papanicolaou; Sensibilidade e Especificidade; Ultrassonografia; Esfregaço Vaginal

Palavras-chave

Autoantibodies; Biomarkers; CA125; DNA methylation; Fallopian tube cytology; Fallopian tube theory of carcinogenesis; HE4; Novel approaches; Ovarian cancer screening; Ovarian cancer screening trials; TP53; Transvaginal ultrasound; ctDNA; miRNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Detecção Precoce de Câncer Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google